2012 HCPCS Code Q0179
Ondansetron hydrochloride 8 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen

HCPCS Q0179 was added on: Wednesday, April 01, 1998

Last date for which HCPCS Q0179 may be used by Medicare providers: Saturday, December 31, 2011.
This code is no longer active.

On Sunday, January 01, 2012, HCPCS Q0179 changed to: Discontinue procedure or modifier code

Type of Service Classification:

Medicare coverage status: D = Special coverage instructions apply

Methodology for developing unique pricing amounts under Medicare Part B:

HCPCS Multiple Pricing Indicator Code: A = Not applicable as HCPCS priced under one methodology

Statute reference for coverage or noncoverage of procedure or service : 4557